Jared T Spletstoser

Title: The Innovative Contributions of Jared T. Spletstoser

Introduction

Jared T. Spletstoser is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of antibacterial compounds, holding two patents that showcase his innovative spirit and dedication to addressing bacterial infections.

Latest Patents

Spletstoser's latest patents include "Substituted Benzazinones as Antibacterial Compounds" and "Peptide Deformylase Inhibitors." The first patent relates to LpxC antibacterial compounds of Formula (IA), which includes corresponding pharmaceutically acceptable salts, pharmaceutical compositions, compound preparation, treatment methods, and uses for bacterial infections, particularly those caused by gram-negative bacteria. The second patent focuses on a compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with corresponding pharmaceutical compositions, compound preparation, and treatment methods aimed at bacterial infections and the inhibition of bacterial peptide deformylase (PDF) activity.

Career Highlights

Throughout his career, Spletstoser has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline Intellectual Property Development Limited. His work in these companies has allowed him to contribute to the advancement of pharmaceutical innovations.

Collaborations

Spletstoser has collaborated with notable colleagues such as Kelly M. Aubart and Andrew B. Benowitz. These partnerships have likely enriched his research and development efforts in the field of antibacterial compounds.

Conclusion

Jared T. Spletstoser's contributions to antibacterial research through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in treating bacterial infections.